Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia

Ítems similars

• Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia
  per: Corentin Orvain, et al.
  Publicat: (2022-08-01)
• Nonmyeloablative allogeneic hematopoietic cell transplantation
  per: Rainer Storb, et al.
  Publicat: (2016-05-01)
• Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia
  per: Daisuke Araki, et al.
  Publicat: (2015-07-01)
• Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML
  per: Naveed Ali, et al.
  Publicat: (2025-02-01)
• Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft-versus-lymphoma effect
  per: Enrico Maffini, et al.
  Publicat: (2018-06-01)